Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,295,140,626
+$7,301,720 QoQ
Shares Held
6,830,190
+4.6% QoQ
Ownership
0.440%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
#32
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $5,256,144,156 across 13 Drug Manufacturers - General names. AZN ranks #1 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
6,830,190 | $1,295,140,626 | |
| 2 | JNJ |
Johnson & Johnson
|
4,873,739 | $1,237,783,491 | |
| 3 | LLY |
ELI LILLY & Co
|
477,197 | $572,364,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,713,343 | $477,164,575 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,275,402 | $476,828,662 | |
| 6 | ABBV |
AbbVie Inc.
|
1,566,077 | $394,087,615 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,853,184 | $360,471,266 | |
| 8 | AMGN |
Amgen Inc
|
636,542 | $230,504,586 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,295,140,626 | 6,830,190 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,287,838,906 | 6,529,961 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||